Noacs et maladie thrombo-embolique veineuse: « translating clinical trials into daily practice » by an international expert, professor giancarlo Agnelli
(2016) Louvain médical — Vol. 135, n° 6, p. 344-351 (2016)
Files
No attached file found for this publication.
Details
- Authors
- Abstract
- (en) ["Translating clinical trials into daily practice" by an international expert, Professor Giancarlo agnelli] Due to the development and approval of new oral anticoagulants (noaCs), the treatment of venous thromboembolic disease (VTE) has changed dramatically over the last years. our therapeutic habits are evolving, thus raising new issues, especially regarding the use of noaCs in daily practice. the first part of this paper reviews major clinical trials that have led to the approval of noaCs for Vte treatment. in the second part, the international expert Giancarlo Agnelli shares his experiences and recommendations regarding the use of noaCs in Vte.
- Affiliations
Citations
Lambert, C. (2016). Noacs et maladie thrombo-embolique veineuse: « translating clinical trials into daily practice » by an international expert, professor giancarlo Agnelli. Louvain médical, 135(6), 344-351. https://hdl.handle.net/2078.5/50439 (Original work published 2016)